World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
24057
World Ranking
15660
National Ranking
1443

Byung-Ho Nam publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Byung-Ho Nam sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 331 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Byung-Ho Nam D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Byung-Ho Nam sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Byung-Ho Nam is affiliated with the National Cancer Research Institute, UK, based in the United Kingdom. Their research primarily centers on the field of Medicine, with significant contributions to subfields including Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology, and Infectious Diseases.

The principal topics of Byung-Ho Nam's work include:

  • Gastric Cancer Management and Outcomes
  • Lung Cancer Treatments and Mutations
  • Colorectal Cancer Treatments and Studies
  • Metastasis and carcinoma case studies
  • Lung Cancer Research Studies
  • COVID-19 Clinical Research Studies
  • COVID-19 and healthcare impacts

Byung-Ho Nam has contributed articles to several academic venues, with frequent publications in:

  • Journal of Clinical Oncology
  • Cancer Research and Treatment
  • Gastric Cancer
  • Scientific Reports
  • Cancer Medicine

Recent notable papers include:

  • Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Rearranged or Translocated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04), 2023, Journal of Clinical Oncology
  • Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial), 2020, Gastric Cancer
  • Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial, 2023, Journal of Clinical Oncology
  • Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma., 2020, Journal of Clinical Oncology
  • Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE), 2022, Cancer Medicine

Frequent collaborators include Myung-Ju Ahn, Min-Hee Ryu, Yoon-Koo Kang, Bhumsuk Keam, and Keun Won Ryu. These partnerships have resulted in multiple joint publications highlighting various oncology and clinical treatment topics.

Best Publications

  • Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.

    Sung-Bum Kang;Ji Won Park;Seung-Yong Jeong;Byung Ho Nam

  • Parental Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged Adults: A Prospective Study of Parents and Offspring

    Donald M. Lloyd-Jones;Byung Ho Nam;Byung Ho Nam;Ralph B. D'Agostino;Ralph B. D'Agostino;Ralph B. D'Agostino;Daniel Levy;Daniel Levy

  • Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.

    Seung Yong Jeong;Seung Yong Jeong;Ji Won Park;Ji Won Park;Byung Ho Nam;Sohee Kim

  • Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial.

    Young-Woo Kim;Yong Hae Baik;Young Ho Yun;Byung Ho Nam

  • Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer

    Il Ju Choi;Myeong Cherl Kook;Young Il Kim;Soo Jeong Cho

  • Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

    Yong Sang Hong;Byung Ho Nam;Kyu pyo Kim;Jeong Eun Kim

  • Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures

    Ralph B. D'Agostino;Byung-Ho Nam

  • Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study

    Jaume Marrugat;Isaac Subirana;Eva Comín;Carmen Cabezas

  • Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?

    Hee Seok Lee;Geon Kook Lee;Hyun-Sung Lee;Moon Soo Kim

  • Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study

    Thomas J. Wang;Byung Ho Nam;Peter W.F. Wilson;Peter W.F. Wilson;Philip A. Wolf;Philip A. Wolf

  • SIBLING CARDIOVASCULAR DISEASE AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE IN MIDDLE-AGED ADULTS

    Joanne M. Murabito;Michael J. Pencina;Michael J. Pencina;Byung Ho Nam;Byung Ho Nam;Ralph B. D'Agostino;Ralph B. D'Agostino

  • A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma

    Joong-Won Park;Ji Hoon Kim;Seok Ki Kim;Keon Wook Kang

  • C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study

    Peter W. F. Wilson;Byung-Ho Nam;Michael Pencina;Ralph B. D’Agostino

  • Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial.

    Min Jung Kim;Sung Chan Park;Ji Won Park;Hee Jin Chang

  • Breast cancer subtypes and survival in patients with brain metastases.

    Byung-Ho Nam;Sun Young Kim;Hye-Sook Han;Youngmee Kwon

  • Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients

    Ju Hyun Shim;Joong Won Park;Ji Hoon Kim;Min An

  • Transbronchial and Transesophageal Fine-Needle Aspiration Using an Ultrasound Bronchoscope in Mediastinal Staging of Potentially Operable Lung Cancer

    Bin Hwangbo;Geon-Kook Lee;Hee Seok Lee;Kun-Young Lim

  • Longitudinal threshold changes in older men with audiometric notches.

    George A. Gates;Peter Schmid;Sharon G. Kujawa;Byung-ho Nam

  • Endogenous sex hormones and cardiovascular disease incidence in men.

    Johan Ärnlöv;Michael J. Pencina;Shreyasee Amin;Byung Ho Nam

  • Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study.

    Joanne M. Murabito;Byung Ho Nam;Ralph B. D'Agostino;Donald M. Lloyd-Jones

Frequent Co-Authors

Ralph B. D'Agostino
Ralph B. D'Agostino Wake Forest University
Christopher J. O'Donnell
Christopher J. O'Donnell Harvard Medical School
Thomas J. Wang
Thomas J. Wang Vanderbilt University
Michael J. Pencina
Michael J. Pencina Duke University
Daniel Levy
Daniel Levy National Institutes of Health
Woo Jin Hyung
Woo Jin Hyung Yonsei University
Yoon-Koo Kang
Yoon-Koo Kang Asan Medical Center
Emelia J. Benjamin
Emelia J. Benjamin Boston University
Peter W.F. Wilson
Peter W.F. Wilson Emory University
Ramachandran S. Vasan
Ramachandran S. Vasan The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Choosing to study Medicine in the USA can open doors to a variety of exciting healthcare careers. If you’re considering different pathways, there are several convenient online degree options tailored for various interests and professional goals.

For those interested in the intersection of technology and patient care, healthcare informatics degree programs provide essential skills in managing health data and information systems. Alternatively, the demand for professionals skilled in medical administration is rising, and you can get started with billing and coding classes online to build a foundation in healthcare finance and records management.

If direct patient care is your passion, nursing remains an in-demand and respected field. There are flexible, reputable study options, including the cheapest online acute care nurse practitioner programs and the cheapest online nursing program. These programs help students gain clinical experience and specialized knowledge, preparing them for advanced nursing roles.

Exploring these related online degrees can help you find a pathway that aligns with your interests, schedule, and career goals in the rapidly evolving healthcare sector.

Best Scientists Citing Byung-Ho Nam

Trending Scientists

Recently Published Articles